STM publisher Elsevier, Netherlands, recently announced that it has acquired US-based Windhover Information Inc., a healthcare business intelligence company that provides analysis and commentary on healthcare business strategy, industry deal making, marketplace trends and medical start-ups. This acquisition is the latest in a series of highly synergistic investments in content, workflow tools and e-Health services. Windhover will operate within Elsevier's Pharma Business Intelligence Unit, which includes F-D-C Reports, Inc. and Inteleos, a drug development database.
The acquisition supports Elsevier's e-Health strategy to improve patient healthcare and the business of health in the Pharma business intelligence market. It expands the global publisher's offering of new products and services for Pharma industry professionals by combining innovative technology and industry-leading content to promote faster and better informed planning and management of product portfolios.
Windhover produces journals such as IN VIVO and the RPM Report; Strategic Transactions Database, a comprehensive database of healthcare industry transactions; and a series of medical-device and biopharmaceutical partnering and strategy conferences. With Windhover, Elsevier will field a team of over 100 journalists in bureaus covering healthcare developments across the globe.
Terms of the acquisition were not disclosed.
More News in this Theme
